V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310006993 | 310004178 | 1.58 | 47.8 | Palliative (P) | 2014-08-26 | 2014-12-09 | Carboplatin + Liposomal Doxorubicin | 2 | null | 310014866 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006994 | 310004178 | 1.6 | null | null | 2016-07-01 | 2017-01-13 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310014866 | GEMCITABINE |
| 310006995 | 310004179 | 1.6 | 116 | Palliative (P) | 2018-02-23 | 2018-03-05 | Carboplatin + Liposomal Doxorubicin | N | N | 310014871 | CARBOPLATIN + LIPOSOMAL DOX |
| 310006996 | 310004180 | 1.93 | 93.3 | Disease modification (D) | 2015-08-15 | 2015-09-25 | Brentuximab | N | N | 310014873 | BRENTUXIMAB |
| 310006997 | 310004182 | 1.84 | 83.1 | Curative (C) | 2016-11-15 | 2017-04-23 | GEMCITABINE | N | null | 310014878 | GEMCITABINE |
| 310006998 | 310004183 | 0 | 87 | Curative (C) | 2016-05-21 | 2016-05-28 | null | N | N | 310014908 | NOT MATCHED |
| 310006999 | 310004184 | null | 91.8 | Disease modification (D) | 2016-07-09 | 2017-01-11 | GEMCITABINE | N | N | 310014908 | GEMCITABINE |
| 310007000 | 310004184 | null | 62 | Palliative (P) | 2014-01-20 | 2014-02-16 | PEMBROLIZUMAB | 99 | N | 310014908 | PEMBROLIZUMAB |
| 310007001 | 310004184 | 1.61 | 58.3 | Disease modification (D) | 2015-02-12 | 2015-02-13 | GEM-P | 02 | N | 310014908 | GEMCITABINE + PACLITAXEL |
| 310007002 | 310004187 | null | 77 | Curative (C) | 2016-01-05 | 2016-01-17 | IVE | N | N | 310014959 | IVE |
| 310007003 | 310004189 | null | 61 | Curative (C) | 2017-02-10 | 2017-02-14 | Brentuximab | 02 | N | 310014972 | BRENTUXIMAB |
| 310007004 | 310007746 | 1.68 | null | Curative (C) | 2015-07-22 | 2015-07-31 | IVE | N | N | 310014991 | IVE |
| 310007005 | 310009631 | 1.57 | 58.3 | Palliative (P) | 2016-12-21 | 2017-01-23 | Gemcitabine weekly | N | N | 310014991 | GEMCITABINE |
| 310007006 | 310004201 | 1.68 | 51.1 | Palliative (P) | 2015-12-30 | 2016-01-21 | AML Interim Guidelines FLA -Ida | Y | N | 310015002 | NOT MATCHED |
| 310007007 | 310004201 | 1.63 | null | Palliative (P) | 2018-01-05 | 2018-05-29 | Carboplatin + Liposomal Doxorubicin | N | N | 310015002 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007008 | 310004202 | 1.28 | 19 | Palliative (P) | 2017-09-25 | 2017-09-26 | Carboplatin + Liposomal Doxorubicin | 02 | null | 310015008 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007009 | 310004203 | 1.68 | 78.6 | Palliative (P) | 2017-10-19 | 2017-10-21 | PEMBROLIZUMAB | 2 | N | 310015028 | PEMBROLIZUMAB |
| 310007010 | 310004204 | 1.57 | 66.2 | Curative (C) | 2013-02-14 | 2013-03-01 | LEAM | 02 | N | 310015039 | LEAM |
| 310007011 | 310004205 | 1.28 | 73.55 | Curative (C) | null | 2015-05-30 | CYCLOPHOSPHAMIDE + prednisalone + ETOPOSIDE + prednisalone + VINCRISTINE + prednisalone | N | N | 310015041 | NOT MATCHED |
| 310007012 | 310004206 | 1.61 | 73.65 | Curative (C) | 2017-01-17 | 2017-01-20 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310015043 | CISPLATIN + GEMCITABINE |
| 310007013 | 310004207 | 1.66 | null | Curative (C) | 2016-09-10 | 2016-09-10 | Carboplatin + Liposomal Doxorubicin | 2 | N | 310015043 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007014 | 310004208 | 1.6 | 78.4 | Not known (9) | 2017-02-17 | 2017-09-12 | Gemcitabine 1000mg/m2 D1 8 15 | 2 | N | 310015056 | GEMCITABINE |
| 310007015 | 310004209 | null | 65.9 | Palliative (P) | null | 2014-02-05 | GEM-P | null | null | 310015060 | GEMCITABINE + PACLITAXEL |
| 310007016 | 310004211 | 1.71 | null | Curative (C) | 2013-10-25 | 2013-10-30 | GEM-P | 02 | N | 310015060 | GEMCITABINE + PACLITAXEL |
| 310007017 | 310004212 | 1.19 | null | Curative (C) | 2017-03-17 | 2017-03-17 | ALCL ALCL 99 Closed AM 1, 2 or 3 | 2 | N | 310015074 | NOT MATCHED |
| 310007018 | 310007755 | 1.61 | 73.6 | Curative (C) | 2012-10-30 | 2013-05-07 | CISPLATIN + GEMCITABINE | 2 | N | 310015077 | CISPLATIN + GEMCITABINE |
| 310007019 | 310007756 | 1.67 | 68.5 | Palliative (P) | 2014-10-02 | 2014-10-11 | GEM-P | Y | N | 310015077 | GEMCITABINE + PACLITAXEL |
| 310007020 | 310007756 | null | 59 | null | 2015-08-26 | 2015-08-26 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310015077 | GEMCITABINE |
| 310007022 | 310004214 | 1.43 | 95 | Curative (C) | 2015-12-18 | 2015-12-18 | NB HRNBL-1 ch14.18/CHO only (trial) | N | null | 310015114 | NOT MATCHED |
| 310007023 | 310004216 | null | null | Not known (9) | 2014-07-12 | 2014-08-01 | PEMBROLIZUMAB | N | N | 310015120 | PEMBROLIZUMAB |
| 310007030 | 310004218 | 0 | 67.5 | Neo-adjuvant (N) | 2015-07-08 | 2015-07-22 | null | 02 | N | 310015181 | NOT MATCHED |
| 310007031 | 310007760 | 1.52 | 61.5 | Curative (C) | 2014-01-22 | 2014-01-30 | BEAM | N | N | 310015182 | BEAM |
| 310007032 | 310009639 | 1.81 | 71.15 | Curative (C) | 2016-02-10 | 2016-02-12 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 310015193 | CISPLATIN + GEMCITABINE |
| 310007033 | 310009639 | 1.58 | 64.7 | Palliative (P) | 2014-04-19 | 2014-04-22 | Carboplatin + Liposomal Doxorubicin | N | null | 310015193 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007034 | 310004219 | 1.89 | 72 | Palliative (P) | 2016-05-21 | 2016-08-07 | Brentuximab | N | N | 310015236 | BRENTUXIMAB |
| 310007035 | 310004219 | 1.96 | 102 | null | 2015-08-22 | 2015-08-22 | IVE | 02 | N | 310015236 | IVE |
| 310007036 | 310004219 | null | 91 | Palliative (P) | 2017-03-23 | 2017-04-02 | GEMCITABINE | N | N | 310015236 | GEMCITABINE |
| 310007037 | 310004220 | 1.57 | 57 | Curative (C) | 2012-11-11 | 2013-07-19 | LEAM | N | N | 310015263 | LEAM |
| 310007038 | 310004221 | null | 76.8 | Curative (C) | 2015-09-23 | 2015-09-29 | Brentuximab | 02 | N | 310015269 | BRENTUXIMAB |
| 310007039 | 310004222 | 1.88 | 74 | null | 2016-04-02 | 2016-04-02 | PEMBROLIZUMAB | N | N | 310015276 | PEMBROLIZUMAB |
| 310007040 | 310004223 | 1.66 | 60.4 | Curative (C) | 2015-01-27 | 2015-02-15 | GEM-P | N | N | 310015279 | GEMCITABINE + PACLITAXEL |
| 310007041 | 310004223 | 1.87 | 75.3 | Disease modification (D) | 2017-12-03 | 2017-12-17 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015279 | CISPLATIN + GEMCITABINE |
| 310007042 | 310004223 | 1.75 | 96.6 | Adjuvant (A) | null | 2014-06-20 | BEAM | N | N | 310015279 | BEAM |
| 310007043 | 310004223 | 1.84 | 74.9 | Palliative (P) | 2017-09-29 | 2017-10-05 | CARBOPLATIN + LIPOSOMAL DOX | 02 | N | 310015279 | CARBOPLATIN + LIPOSOMAL DOX |
| 310007044 | 310004225 | 0.92 | 67.4 | Curative (C) | 2015-10-17 | 2015-10-19 | null | 02 | N | 310015305 | NOT MATCHED |
| 310007045 | 310007764 | 1.7 | 108 | Curative (C) | 2017-12-20 | 2017-12-29 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310015311 | GEMCITABINE |
| 310007046 | 310007764 | 1.78 | 67.3 | Curative (C) | 2017-10-06 | 2017-10-06 | GEM-P | N | null | 310015311 | GEMCITABINE + PACLITAXEL |
| 310007047 | 310004227 | 1.94 | 93.2 | Palliative (P) | 2014-02-09 | 2014-03-02 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310015321 | CISPLATIN + GEMCITABINE |
| 310007048 | 310004227 | 1.61 | null | Curative (C) | 2017-07-22 | 2017-07-30 | PCE2BO (Etopophos®) | 2 | N | 310015321 | NOT MATCHED |
| 310007049 | 310004229 | 1.64 | 89 | Curative (C) | null | 2019-01-16 | Brentuximab Vedotin | N | N | 310015333 | BRENTUXIMAB |